FOXA1, a pioneer factor that maintains epithelial identity and mediates AR cistrome engagement, has been previously implicated in prostate tumorigenesis and therapeutic resistance, particularly through mutations and enhancer reprogramming [21,60,61]. The gene discussed is AR; the disease is medical procedure.